Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tamara Marsden"'
Autor:
Fei Yuan, Jackie Bosch, John Eikelboom, Gilles R Dagenais, Stuart Connolly, Jane Belanger, Tamara Marsden, Cissy Tang, Balakumar Swaminathan, Martin Renters, Leanne Dyal, Shrikant I Bangdiwala
Publikováno v:
Clinical Trials. 20:166-175
Introduction: In clinical trials, event adjudication is a process to review and confirm the accuracy of outcomes reported by site investigators. Despite efforts to automate the communication between a clinical-data-and-coordination center and an even
Autor:
John W. Eikelboom, Deepak L. Bhatt, Scott D. Berkowitz, Jackie Bosch, Tamara Marsden, Derek L Connolly, Kelley R. Branch, Dragos Vinereanu, Keith A.A. Fox, Kevin R. Bainey, Jeffrey L. Probstfield, Petr Widimsky, Robert C. Welsh, Salim Yusuf, Basil S. Lewis, Rafael Diaz, Stuart J. Connolly, Eva Muehlhofer, P. Gabriel Steg, JoAnne M. Foody
Publikováno v:
Circulation. 141:1141-1151
Background: The COMPASS trial (Cardiovascular Outcomes for People using Anticoagulation Strategies) demonstrated that dual pathway inhibition (DPI) with rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily versus aspirin 100 mg once daily re
Autor:
François Dagenais, Petr Widimsky, John W. Eikelboom, Tamara Marsden, Eva Lonn, Salim Yusuf, Shun Fu Lee, Ingrid Copland, Gilles R. Dagenais, Jackie Bosch, Zhe Zheng, Deepak L. Bhatt, Andre Lamy, Keith A.A. Fox, Jun Zhu, Zbynek Straka, Kelly R.H. Branch, Stuart J. Connolly, Tej Sheth, Ye Kong
Publikováno v:
Journal of the American College of Cardiology. 73:121-130
Background Patients with recent coronary artery bypass graft (CABG) surgery are at risk for early graft failure, which is associated with a risk of myocardial infarction and death. In the COMPASS (Cardiovascular OutcoMes for People Using Anticoagulat
Autor:
Fatima Merali, William F. McIntyre, Jeff S. Healey, Sam Henein, Katharina Schmalstieg-Bahr, F. Russell Quinn, Noah Ivers, Doris von Grünhagen, Andrea Thornton, Stuart J. Connolly, Tamara Marsden, Johanna Suerbaum, Eva Hummers, Coordinators, David J. Gladstone, Screen-Af Investigators, Rolf Wachter, Jorge A. Wong, Alexander P. Benz, Chris Nichol, Angie Djuric
Publikováno v:
JAMA cardiology. 6(5)
Atrial fibrillation (AF) is a major cause of preventable strokes. Screening asymptomatic individuals for AF may increase anticoagulant use for stroke prevention.To evaluate 2 home-based AF screening interventions.This multicenter randomized clinical
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease
Autor:
Jorge A. Wong, William F. McIntyre, Ganesan Karthikeyan, Jeff S. Healey, Jonas Oldgren, Stuart J. Connolly, John W. Eikelboom, Albertino Damasceno, Salim Yusuf, Stefan H. Hohnloser, Tamara Marsden, Lars Wallentin, Michael D. Ezekowitz, Patrick J. Commerford, Ashley Chin, Alexander P. Benz
Publikováno v:
Cardiovascular research. 118(1)
AIMS Patients with atrial fibrillation (AF) and rheumatic heart disease (RHD), especially mitral stenosis, are assumed to be at high risk of stroke, irrespective of other factors. We aimed to re-evaluate stroke risk factors in a contemporary cohort o
Autor:
Shaheen Pandie, Christopher L. Gordon, Shun Fu Lee, Tej Sheth, Michael Rokoss, Kiersten Colbran, Brandi Meeks, Madhu K. Natarajan, Ashraf Alazzoni, Nicholas Valettas, James L. Velianou, Jaffer Syed, Shamir R. Mehta, Sanjit S. Jolly, Ed Waller, Jon-David Schwalm, Darar Al Khdair, Michael Tsang, Tamara Marsden
Publikováno v:
Circulation. Cardiovascular interventions. 8(8)
Background— Interventional cardiologists receive one of the highest levels of annual occupational radiation exposure. Further measures to protect healthcare workers are needed. Methods and Results— We evaluated the efficacy of a pelvic lead shiel
Autor:
Goran Stankovic, Vladimir Dzavik, Jon-David Schwalm, John A. Cairns, Pablo Lamelas, Brandi Meeks, Sasko Kedev, Tej Sheth, Shamir R. Mehta, Madhu K. Natarajan, Ashraf M. Al Azzoni, Sunil V. Rao, Sanjit S. Jolly, Tamara Marsden
Publikováno v:
Journal of the American College of Cardiology. 69:1179
Background: No-reflow during percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI) has been previously associated with worse outcomes. The TOTAL trial showed that routine thrombus aspiration did not reduce the incide